Bitcoin Generation Inc. (BTGN)

[beentomyrasite]

HUGE NEWS out today

http://finance.yahoo.com/news/InoLife-Technologies-Inc-pz-1025334111.html?x=0&.v=1

InoLife Technologies, Inc. Delivers Product to Gulf Coast Pharmaceuticals

Delivery is the First Under the Terms of the Sales Distribution Agreement


Companies:Inolife Technologies, Inc.
Related Quotes
Symbol Price Change
INOL.PK 0.00 0.00

Press Release Source: InoLife Technologies, Inc. On Thursday June 2, 2011, 8:30 am
RALEIGH, N.C. and OCEAN SPRINGS, Miss., June 2, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL - News), an innovative healthcare products development and marketing company has announced the first delivery of its highly competitive DNA-based products to Gulf Coast Pharmaceuticals, Inc. for distribution and sales nationwide. The delivery included over $300,000 of the company's signature DNA-based products. Gulf Coast is a pharmaceutical supply company specializing in the nationwide distribution of pharmaceuticals and medical supplies to the healthcare industry.

"This initial delivery of our products is the first of what we project to be many, under our Agreement with Gulf Coast. Gulf Coast will sell our products to its current base of consumers, hospitals, general practitioners and cardiologists," said Gary Berthold, CEO of InoLife. "We believe our Genetic Predisposition Test is superior to those in the marketplace and we expect it will continue to receive broad acceptance as Gulf Coast markets this first delivery of inventory for re-sale This DNA test reveals genetic predispositions for 25 diseases and conditions in five major categories. Gulf Coast will also distribute InoLife's Cytochrome CYP2C19drug metabolism analysis, a test that determines if a patient has a genetic variation that may reduce the effectiveness of Plavix. If that patient has the genetic variation, the risk of having a stroke, heart attack or other serious cardiac event is higher.